Allergan (AGN) Q2 2012 Earnings Call August 01, 2012 11:00 am ET Executives James M. Hindman - Chief Financial Officer David E. I. Pyott - Chairman, Chief Executive officer and President Jeffrey L. Edwards - Chief Financial Officer and Executive Vice President of Finance & Business Development Scott M. Whitcup - Chief Scientific Officer and Executive Vice President of Research & Development Joann Bradley Analysts Shibani Malhotra - RBC Capital Markets, LLC, Research Division Catherine J. Arnold - Crédit Suisse AG, Research Division David Risinger - Morgan Stanley, Research Division Gregory B. Gilbert - BofA Merrill Lynch, Research Division Aaron Gal - Sanford C. Bernstein & Co., LLC., Research Division Frank H. Pinkerton - SunTrust Robinson Humphrey, Inc., Research Division Rebecca M. Forest - Piper Jaffray Companies, Research Division Ken Cacciatore - Cowen and Company, LLC, Research Division Seamus Fernandez - Leerink Swann LLC, Research Division Annabel Samimy - Stifel, Nicolaus & Co., Inc., Research Division Marc Goodman - UBS Investment Bank, Research Division David G. Buck - The Buckingham Research Group Incorporated Steve Willoughby - Cleveland Research Company Douglas D. Tsao - Barclays Capital, Research Division Lawrence Biegelsen - Wells Fargo Securities, LLC, Research Division Gary Nachman - Susquehanna Financial Group, LLLP, Research Division Gregory Waterman - Goldman Sachs Group Inc., Research Division PresentationOperator
Hello, and welcome to the Allergan Second Quarter 2012 Earnings Call. [Operator Instructions] At the request of the company, today's conference is being recorded. If anyone has any objections, you may disconnect at this time. I would like to introduce today's conference host, Mr. Jim Hindman, Senior Vice President, Treasury, Risk and Investor Relations. Sir, you may begin.